BGCKX | JMNSX | BGCKX / JMNSX | |
Total Expense Ratio | 1.29 | 2.46 | 52% |
Annual Report Gross Expense Ratio | 1.31 | 2.59 | 51% |
Fund Existence | 10 years | 16 years | - |
Gain YTD | 11.259 | 3.780 | 298% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 1000000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 408M | 1,687% |
Annual Yield % from dividends | 9.94 | 2.41 | 412% |
Returns for 1 year | 13.65 | 3.45 | 396% |
Returns for 3 years | 60.24 | 31.41 | 192% |
Returns for 5 years | 60.80 | 22.81 | 267% |
Returns for 10 years | N/A | 15.19 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXLIX | 14.34 | 0.06 | +0.42% |
Impax Large Cap Fund Institutional | |||
FIRAX | 10.33 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate A | |||
GIRMX | 29.64 | -0.05 | -0.17% |
Goldman Sachs Emerging Markets Eq Inv | |||
BIPIX | 56.46 | -0.10 | -0.18% |
ProFunds Biotechnology UltraSector Inv | |||
MINJX | 45.87 | -0.31 | -0.67% |
MFS International Intrinsic Value R6 |